6 active not recruiting. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Active not recruiting 6 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Hypopigmentation: new trials by email Literature Review of Hypopigmentation trials Research Report on Hypopigmentation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical Delgocitinib for Facial Vitiligo Delgocitinib cream - Vitiligo | Phase 2 | Active not recruiting | Lone Skov | 12 | 2026-04-08 | 2026-09-15 |
| A Trial of SHR0302Base in Patients With Vitiligo SHR0302Base gel, SHR0302Base gel placebo - Vitiligo | Phase 2 | Active not recruiting | Jiangsu HengRui Medicine Co., Ltd. | 155 | 2025-02-13 | 2026-01-15 |
| Topical Ruxolitinib Evaluation in Immune-related Vitiligo-like Depigmentation Ruxolitinib Topical Cream - Immune-related Vitiligo-like-Depigmentation | Phase 2 | Active not recruiting | University of Zurich | 34 | 2024-07-25 | 2026-07-24 |
| Vitiligo Treatment by Targeting TYK2 Mediated Responses Deucravacitinib, Volunteer without treatment - Vitiligo, Generalized | Phase 2 | Active not recruiting | Centre Hospitalier Universitaire de Nice | 128 | 2024-05-05 | 2026-05-20 |
| Effectiveness of Omega-3 Poly Unsaturated Fatty Acids on The Treatment of Gingival Hyperpigmentation non surgical with PUFA injection, surgical treatment - Hyperpigmentation, Gingival Hyperpigmentaion | Phase 1 / Phase 2 | Active not recruiting | Suez Canal University | 30 | 2024-01-03 | 2025-07-16 |
| Daily Topical Rapamycin for Vitiligo Rapamycin, Placebo - Vitiligo | Phase 2 | Active not recruiting | Medical University of South Carolina | 20 | 2022-07-28 | 2026-03-05 |
Vitiligo (6) · Facies (1) · Hyperpigmentation (1) · Lichen Sclerosus et Atrophicus (1)
Pigmentation Disorders (6) · Skin Diseases (6) · Skin and Connective Tissue Diseases (6) · Disease Attributes (1) · Lichenoid Eruptions (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Skin Diseases, Papulosquamous (1)
Fatty Acids, Unsaturated (1) · Sirolimus (1) · Surgical Procedures, Operative (1) · Therapeutics (1) · deucravacitinib (1) · ruxolitinib (1)
Centre Hospitalier Universitaire de Nice (1) · Jiangsu HengRui Medicine Co., Ltd. (1) · Lone Skov (1) · Medical University of South Carolina (1) · Suez Canal University (1) · University of Zurich (1)
China (1) · Denmark (1) · Egypt (1) · France (1) · Switzerland (1) · United States (1)
Ahmad Aleisa, MD (1) · Lone Skov, MD Prof (1)
2023 (1), 2025 (1)